RESUME BLITZ, an event sponsored by Career Services, is scheduled for September 8th and 9th from 10:00am-3:00pm.  This yearly event is held the week before the fall 2009 Career Fair. Employers voluntarily come in and critique resumes in preparation of the Career Fair. This is a great opportunity to get positive feedback about your resume from an experienced employer. This event only happens once a year, so do not miss this opportunity! Bring your resume and stop by the following rooms:

Tuesday, September 8 and/or Wednesday, September 9
10:00 AM – 3:00 PM

Biomedical Engineering in BME Rooms 1118 & 4101 and IBB Rooms 1316 & 1317
Aerospace Engineering in Guggenheim 317
Civil & Environmental Engineering in Mason Building Lobby
Electrical & Computing Engineering in Van Leer Building, W218
Industrial & Systems Engineering in ISYE Building Atrium
Mechanical Engineering, PTFE and MSE in Marc Building, Marc Auditorium

For additional questions about the event, please contact Career Services at 404-894-3738.  If you are unable to make any of the above times please go to Career Services – Bill Moore Student Success Center, Basement Level on Friday, September 11, 2009 – 10:00 AM – 3:00 PM.

Please see attached document for more information about location:

resume_blitz_locations_2009

The LIFE (Learn about Industry From Experts) seminar series presents:

Regenerative Medicine: Revolutionary Technology and Unique Development Challenges

Thomas Spencer, Ph.D.

Director, Applied Biosciences

Tengion, Inc.

Wednesday, May 13th, 11am-12pm

IBB Seminar Room (#1128)

LUNCH Provided!

Tom Spencer is a scientist with over 17 years of research, development and manufacturing experience.  Tom currently is a Director in the Bioprocess Research and Development group at Tengion Laboratories in Winston-Salem, NC.  Tengion is a leader in the field of Regenerative Medicine, developing novel treatments for tissue and organ failure.  Tom has extensive knowledge of GMP manufacturing and his expertise includes experimental design and statistical modeling for product testing and process development.  Tom has a BS and PhD in Biochemistry from Virginia Tech.  

This talk will be a presentation of Tengion’s products and technology, with specific details about the Neo-Bladder Augment™ and discussion of how the development of Regenerative Medicine products compare to established medical therapies.

Thanks!

BBUGS Industry Committee

Dear Graduate Students,

On May 19th, Georgia Tech will be hosting a party out in the quad for around 300-500 people for the BIO conference that will be in town.  We are looking for 30 volunteers to work the event that evening in three hour shifts 4:00pm- 7:00pm and 7:00pm to 10:00pm.  The event itself is from 6pm-9pm.

Who is invited? Faculty and business professionals from around the state and across the country.

What is in it for you? An invitation to Tech’s largest party which will provide you networking opportunities and a good meal.

What will you be asked to do? There is a wide variety of things that we will need people to do from directing visitors, to registering people as they come in, to moving tables and chairs, to riding shuttles so that the shuttle drivers do not get lost, and posting signs around campus.

Please let me know if you are available, which shift you have a preference for and if you have any physical restrictions: megan.mcdevitt@ibb.gatech.edu

Thanks in advance for your help.
Meg

The LIFE (Learn about Industry From Experts) seminar series presents:

‘Biogenerics:   The Next Big Money Battleground between Pharmaceutical Companies and the Generics Industry’ by

Paul Salo, Ph.D.
Technical Advisor, Merchant & Gould, LLC

When: Tuesday, April 21st, 4pm-5pm
Where: IBB Seminar Room (#1128 IBB)

Food and drink will be provided!!

Paul is a Technical Advisor in the Atlanta office of Merchant & Gould, and assists in the preparation and prosecution of patent applications and provides technical expertise in support of freedom to operate and invalidity opinions.  He graduated from Georgia Tech in 2007 with a Ph.D. in Biochemistry and was in the TI:GER (Technological Innovation: Generating Economic Results) Program. In 2003, Paul earned a M.S. in Paper Science and Engineering from the Institute of Paper Science and Technology at Georgia Tech.

During the past several years, there has been increasing interest in the development of follow-on biologic products in light of advances in manufacturing technology, process control, and protein characterization.  The term biogenerics, or follow-on biologic products, generally refers to proteins and peptides that are intended to be sufficiently similar to a product already approved under the Federal Food, Drug, and Cosmetic Act, or licensed under the Public Health Service Act, to permit the applicant to rely on certain existing scientific knowledge about the safety and effectiveness of the approved biologic product.  Biogeneric products may be produced through biotechnology or derived from natural sources.  The FDA has been considering the circumstances in which review and approval of biogeneric products may be appropriate.  In addition, biogenerics legislation is currently pending in Congress and will likely pass this year.  This presentation will examine the legal, regulatory, and scientific issues surrounding biogenerics.

Thanks!

BBUGS Industry Committee

2009 BIO Career Fair

Considering a new career?  Have an opening at your company?  Consider participating at the 2009 BIO Career Fair, Monday, May 18 at the Georgia World Congress Center.  BIO Career Fair is FREE to all job seekers. You don’t need to attend the event to upload your resume.  Employers can exhibit, post a job, sponsor, or advertise in the onsite program.  Posting jobs on the BIO Career Fair website will market your jobs to thousands of job seekers PLUS it will be automatically cross-posted to BioSpace.com! Your jobs will be viewable to the largest bioscience audience in the industry.  Learn more at www.biocareerfair.org.

The LIFE (Learn about Industry From Experts) seminar series presents:

‘Development of New Technology: Concept Evaluation‘ by

Steven Shaya, Ph.D.
Transform Consulting, LLC

When: Wednesday, January 14th, 9:30am-10:30am
Where: IBB Seminar Room (#1128 IBB)

Food and drink will be provided!!

Dr. Shaya retired as a Vice President in Johnson & Johnson’s Corporate Office of Science & Technology in 2007.  His role was to identify emerging technologies with the potential to disrupt health care categories, build connections to key research in these areas, and support adoption into J&J’s product development structure. His scope of interests is as broad as that of J&J’s 200 subsidiary health care companies.  In retirement, he started a consultant firm and consults on assessment and development of emerging science.

Dr. Shaya’s areas of focus have been tissue engineering, novel drug delivery platforms, patient monitoring and diagnostic business models.  He has patents for informatic services and monitors to impact medical outcomes. Steve has experience building and managing alliances across firms and created a novel infrastructure to enable collaboration across J&J’s decentralized R&D community.

This talk will provide an overview of the decision process of beginning or continuing an R&D project in industry. The decision is based on evaluation of costs, time, and risks of the entire development path as well as the potential for market profits.  An example project will be evaluated for scientific, technological, patent, clinical, manufacturing, and marketing risks and potential.  The net present value of the entire development and marketing phases of the product will be calculated in order to decide on project initiation or survival.

Thanks!

BBUGS Industry Committee

The LIFE (Learn about Industry From Experts) seminar series presents:

‘Commercial Development of Cell-Based Products in the Regenerative Medicine Industry’ by

Chris V. Gemmiti, Ph.D.
Product Director,
Organogenesis Inc.

When: Monday, January 12th, 4pm-5pm
Where: IBB Seminar Room (#1128 IBB)

Food and drink will be provided!!

Dr. Chris Gemmiti is currently a Product Director at Organogenesis and formerly a PhD candidate in the Guldberg lab in the BME program. Chris worked in R&D as a Biomedical Engineer at Organogenesis from 1997-2001 when he enrolled in Georgia Tech / Emory’s BME PhD Program.  Upon graduating in 2006, Chris re-joined Organogenesis in a very different capacity than his first stint, this time as Manager of Early Commercial Development.  Chris will share his diverse experience from industry research, academic research and industry commercial development, all from the perspective of a former BME PhD student.

This seminar will focus on tissue engineering / regenerative medicine in industry as told by a former Georgia Tech BME PhD student. Careers paths and choices in different industry capacities will be broadly presented, followed by a more focused discussion on commercial strategy at a regenerative medicine company.  This includes outlining the mechanisms of how research projects are evaluated and translated into developed products, as well as a discussion as to how skill sets learned during academic research can be translated into the commercial side of industry.

See you at 4!

BBUGS Industry Committee

The LIFE (Learn about Industry From Experts) seminar series presents:

‘Development of New Technology: Concept Evaluation‘ by

Steven Shaya, Ph.D.
Transform Consulting, LLC

When: Wednesday, January 14th, 9:30am-10:30am
Where: IBB Seminar Room (#1128 IBB)

Food and drink will be provided!!

Dr. Shaya retired as a Vice President in Johnson & Johnson’s Corporate Office of Science & Technology in 2007.  His role was to identify emerging technologies with the potential to disrupt health care categories, build connections to key research in these areas, and support adoption into J&J’s product development structure. His scope of interests is as broad as that of J&J’s 200 subsidiary health care companies.  In retirement, he started a consultant firm and consults on assessment and development of emerging science.

Dr. Shaya’s areas of focus have been tissue engineering, novel drug delivery platforms, patient monitoring and diagnostic business models.  He has patents for informatic services and monitors to impact medical outcomes. Steve has experience building and managing alliances across firms and created a novel infrastructure to enable collaboration across J&J’s decentralized R&D community.

This talk will provide an overview of the decision process of beginning or continuing an R&D project in industry. The decision is based on evaluation of costs, time, and risks of the entire development path as well as the potential for market profits.  An example project will be evaluated for scientific, technological, patent, clinical, manufacturing, and marketing risks and potential.  The net present value of the entire development and marketing phases of the product will be calculated in order to decide on project initiation or survival.

Thanks!

BBUGS Industry Committee

The LIFE (Learn about Industry From Experts) seminar series presents:

‘Commercial Development of Cell-Based Products in the Regenerative Medicine Industry’ by

Chris V. Gemmiti, Ph.D.
Product Director,
Organogenesis Inc.

When: Monday, January 12th, 4pm-5pm
Where: IBB Seminar Room (#1128 IBB)

Food and drink will be provided!!

Dr. Chris Gemmiti is currently a Product Director at Organogenesis and formerly a PhD candidate in the Guldberg lab in the BME program. Chris worked in R&D as a Biomedical Engineer at Organogenesis from 1997-2001 when he enrolled in Georgia Tech / Emory’s BME PhD Program.  Upon graduating in 2006, Chris re-joined Organogenesis in a very different capacity than his first stint, this time as Manager of Early Commercial Development.  Chris will share his diverse experience from industry research, academic research and industry commercial development, all from the perspective of a former BME PhD student.

This seminar will focus on tissue engineering / regenerative medicine in industry as told by a former Georgia Tech BME PhD student. Careers paths and choices in different industry capacities will be broadly presented, followed by a more focused discussion on commercial strategy at a regenerative medicine company.  This includes outlining the mechanisms of how research projects are evaluated and translated into developed products, as well as a discussion as to how skill sets learned during academic research can be translated into the commercial side of industry.

See you Monday!

BBUGS Industry Committee

The Biotechnology Career Fair is organizing the following Company Information Sessions:

Wednesday, 9/10
Edwards Lifesciences
6-7pm Whitaker 1103

Wednesday, 9/10
St. Jude Medical
7-8pm IBB 1128

Friday, 9/12
W.L. Gore & Associates
10-11am IBB 1128

Find out more about these companies and the jobs available for bioengineering and biosciences students.

Biotech Career Fair Committee